{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:36:40Z","timestamp":1788910600596,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004001","name":"Guizhou Province Science and Technology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ejpb.2021.05.028","type":"journal-article","created":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T23:12:04Z","timestamp":1623625924000},"page":"103-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Chlorogenic acid sustained-release gel for treatment of glioma and hepatocellular carcinoma"],"prefix":"10.1016","volume":"166","author":[{"given":"Hongli","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenqi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2021.05.028_b0005","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Natl Canc Inst Canada Clin, Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejpb.2021.05.028_b0010","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/neuonc\/nov031","article-title":"Toward precision medicine in glioblastoma: the promise and the challenges","volume":"17","author":"Prados","year":"2015","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.ejpb.2021.05.028_b0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijpharm.2014.06.005","article-title":"Sustained delivery of cytarabine-loaded vesicular phospholipid gels for treatment of xenografted glioma","volume":"472","author":"Qi","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2021.05.028_b0020","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jconrel.2019.12.010","article-title":"Target delivering paclitaxel by ferritin heavy chain nanocages for glioma treatment","volume":"323","author":"Liu","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2021.05.028_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2019.114428","article-title":"Targeted therapy for hepatocellular carcinoma: Challenges and opportunities","volume":"460","author":"Chen","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejpb.2021.05.028_b0035","doi-asserted-by":"crossref","unstructured":"F.C. Barcelos, G.C. de Matos, M.J. Sobreira da Silva, F.A. Barbosa da Silva, E.d.C. Lima, Suspected Adverse Drug Reactions Related to Breast Cancer Chemotherapy: Disproportionality Analysis of the Brazilian Spontaneous Reporting System, Frontiers in Pharmacology, 10 (2019).","DOI":"10.3389\/fphar.2019.00498"},{"key":"10.1016\/j.ejpb.2021.05.028_b0040","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/neuonc\/nos056","article-title":"Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system","volume":"14","author":"Sarganas","year":"2012","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.ejpb.2021.05.028_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00473","article-title":"The Antitumor Activities of Marsdenia tenacissima","volume":"8","author":"Wang","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejpb.2021.05.028_b0050","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jnutbio.2017.04.007","article-title":"Chlorogenic acid inhibits hepatocellular carcinoma in vitro and in vivo","volume":"46","author":"Yan","year":"2017","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.ejpb.2021.05.028_b0055","doi-asserted-by":"crossref","DOI":"10.3390\/ph12030110","article-title":"Safety Pharmacological Evaluation of the Coffee Component, Caffeoylquinic Acid, and Its Metabolites, Using Ex Vivo and In Vitro Profiling Assays","volume":"12","author":"Amano","year":"2019","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejpb.2021.05.028_b0060","doi-asserted-by":"crossref","first-page":"6745","DOI":"10.7150\/thno.34674","article-title":"Chlorogenic acid effectively treats cancers through induction of cancer cell differentiation","volume":"9","author":"Huang","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.ejpb.2021.05.028_b0065","article-title":"Chlorogenic Acid Decreases Malignant Characteristics of Hepatocellular Carcinoma Cells by Inhibiting DNMT1 Expression","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejpb.2021.05.028_b0070","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/1541-4337.12518","article-title":"Bioavailability and metabolism of chlorogenic acids (acyl-quinic acids) in humans","volume":"19","author":"Clifford","year":"2020","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"key":"10.1016\/j.ejpb.2021.05.028_b0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2016.09.034","article-title":"Anticancer drug-loaded hydrogels as drug delivery systems for the local treatment of glioblastoma","volume":"243","author":"Bastiancich","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2021.05.028_b0080","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijpharm.2017.06.013","article-title":"Paclitaxel loaded phospholipid-based gel as a drug delivery system for local treatment of glioma","volume":"528","author":"Chen","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2021.05.028_b0085","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ijpharm.2016.01.081","article-title":"Enhanced oral bioavailability and in vivo antioxidant activity of chlorogenic acid via liposomal formulation","volume":"501","author":"Feng","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2021.05.028_b0090","article-title":"Construction of chlorogenic acid-containing liposomes with prolonged antitumor immunity based on T cell regulation","author":"Zhang","year":"2020","journal-title":"Science China-Life Sciences"},{"key":"10.1016\/j.ejpb.2021.05.028_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119707","article-title":"Comparison of three in-situ gels composed of different oil types","volume":"587","author":"Zhang","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2021.05.028_b0100","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jconrel.2016.01.054","article-title":"Lauroyl-gemcitabine-loaded lipid nanocapsule hydrogel for the treatment of glioblastoma","volume":"225","author":"Bastiancich","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2021.05.028_b0105","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jconrel.2016.03.036","article-title":"Pharmacokinetic and pharmacodynamic study of a phospholipid-based phase separation gel for once a month administration of octreotide","volume":"230","author":"Wang","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2021.05.028_b0110","doi-asserted-by":"crossref","first-page":"20348","DOI":"10.1021\/acsami.7b02303","article-title":"Ligand-Mediated and Enzyme-Directed Precise Targeting and Retention for the Enhanced Treatment of Glioblastoma","volume":"9","author":"Ruan","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejpb.2021.05.028_b0115","first-page":"694","article-title":"Targeted delivery of chlorogenic acid by mannosylated liposomes to effectively promote the polarization of TAMs for the treatment of glioblastoma","volume":"5","author":"Ye","year":"2020","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.ejpb.2021.05.028_b0120","doi-asserted-by":"crossref","DOI":"10.1186\/s12868-018-0447-7","article-title":"Assessment of brain beta-amyloid deposition in transgenic mouse models of Alzheimer's disease with PET imaging agents F-18-flutemetamol and F-18-florbetaben","volume":"19","author":"Son","year":"2018","journal-title":"Bmc Neuroscience"},{"key":"10.1016\/j.ejpb.2021.05.028_b0125","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1021\/acsami.8b16219","article-title":"D-T7 Peptide-Modified PEGylated Bilirubin Nanoparticles Loaded with Cediranib and Paclitaxel for Antiangiogenesis and Chemotherapy of Glioma","volume":"11","author":"Yu","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejpb.2021.05.028_b0130","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijpharm.2019.01.048","article-title":"Spontaneously formed porous structure and M-1 polarization effect of Fe3O4 nanoparticles for enhanced antitumor therapy","volume":"559","author":"Gong","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2021.05.028_b0135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jconrel.2017.08.019","article-title":"Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection","volume":"264","author":"Bastiancich","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2021.05.028_b0140","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jcis.2017.07.047","article-title":"Enzyme-sensitive gemcitabine conjugated albumin nanoparticles as a versatile theranostic nanoplatform for pancreatic cancer treatment","volume":"507","author":"Han","year":"2017","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejpb.2021.05.028_b0145","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1039\/C9NR09585C","article-title":"A new tandem peptide modified liposomal doxorubicin for tumor \u201cecological therapy\u201d","volume":"12","author":"Zhao","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejpb.2021.05.028_b0150","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/psc.2725","article-title":"Peptide internalization enabled by folding: triple helical cell-penetrating peptides","volume":"21","author":"Shinde","year":"2015","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.ejpb.2021.05.028_b0155","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1021\/acs.molpharmaceut.7b01035","article-title":"Hyaluronic Acid-Modified Micelles Encapsulating Gem-C-12 and HNK for Glioblastoma Multiforme Chemotherapy","volume":"15","author":"Liu","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2021.05.028_b0160","article-title":"Photoswitchable Ultrafast Transactivator of Transcription (TAT) Targeting Effect for Nanocarrier-Based On-Demand Drug Delivery","volume":"28","author":"Wang","year":"2018","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ejpb.2021.05.028_b0165","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biomaterials.2016.09.001","article-title":"Development of a multi-target peptide for potentiating chemotherapy by modulating tumor microenvironment","volume":"108","author":"Song","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2021.05.028_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25194553","article-title":"Anti-Cancer Effects of Green Tea Epigallocatchin-3-Gallate and Coffee Chlorogenic Acid","volume":"25","author":"Hayakawa","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2021.05.028_b0175","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201802227","article-title":"Acid-Responsive Transferrin Dissociation and GLUT Mediated Exocytosis for Increased Blood-Brain Barrier Transcytosis and Programmed Glioma Targeting Delivery","volume":"28","author":"Ruan","year":"2018","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ejpb.2021.05.028_b0180","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cis.2015.02.002","article-title":"Encapsulation, protection, and release of hydrophilic active components: Potential and limitations of colloidal delivery systems","volume":"219","author":"McClements","year":"2015","journal-title":"Adv. Colloid Interface Sci."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121001594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121001594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:44:04Z","timestamp":1760546644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641121001594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":35,"alternative-id":["S0939641121001594"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.05.028","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chlorogenic acid sustained-release gel for treatment of glioma and hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}